Safety, and Efficacy of a New Buccal Film of Montelukast in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03402503 · COMPLETED
Trial details
- NCT number
- NCT03402503
- Sponsor
- IntelGenx Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2024-03-13
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.